Reducing racial/ethnic inequities in childhood cancer survivorship
减少儿童癌症幸存者中的种族/民族不平等
基本信息
- 批准号:9245568
- 负责人:
- 金额:$ 41.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-07-03 至 2019-03-31
- 项目状态:已结题
- 来源:
- 关键词:AcculturationAcute Lymphocytic LeukemiaAdherenceAdministratorAdultAffectAgeAttitudeBehavioralBeliefCancer SurvivorshipCaringCessation of lifeChildChildhood Cancer Survivor StudyClinicClinicalClinical OncologyCommunitiesComorbidityCountyDiagnosisDiseaseDropsEducationEmploymentGuidelinesHealthHealth InsuranceHealth PromotionHealth Services AccessibilityHealth StatusHealth behaviorHealthcareHispanicsHospitalsInsuranceJournalsKnowledgeLate EffectsLifeLong-Term EffectsLos AngelesMalignant Childhood NeoplasmMalignant NeoplasmsMarriageMedicalMedical RecordsNot Hispanic or LatinoOncologistOutcomePatientsPediatric Oncology GroupPhysiciansPoliciesPopulation StudyPosttraumatic growthPrimary Care PhysicianPrimary Health CareProviderPsychological FactorsPublishingRecommendationRecording of previous eventsRecruitment ActivityReportingResearchRiskRisk FactorsSelf CareSelf EfficacySurveysSurvivorsSymptomsTimeVisitWorkbasecancer therapychildhood cancer mortalitychildhood cancer survivorcohortcomparativeemerging adultemerging adulthoodethnic differenceexperiencefollow-uphealth care availabilityhealth care service utilizationhealth disparityhigh riskimprovedmortalitypopulation basedpreventpublic health relevanceracial and ethnicsexsocialsocioeconomicssurvivorshiptreatment site
项目摘要
DESCRIPTION (provided by applicant): Despite improved survival, childhood cancer survivors (CCS) are at high risk of late and long term effects from their disease and rigorous treatment. Hispanic CCS, who are underrepresented in survivorship research, show significant health inequities in mortality compared to non-Hispanics. Although life-long, risk based follow-up care is recommended for CCS, use of this care drops rapidly as CCS enter emerging adulthood. Our preliminary work among CCS treated at two hospitals (ages 14-26 when surveyed) indicates that cancer related follow-up care is significantly lower among Hispanic (vs. non-Hispanic) CCS during the early years of emerging adulthood (ages 21-26). We propose to recruit and survey a population-based cohort (n=1,232) of emerging adult (ages 18-39) Hispanic (54%) and non-Hispanic CCS to understand potential inequities in the receipt of recommended follow-up care, as well as factors that may differentially affect health outcomes of Hispanic and non-Hispanic CCS. Our aims are to determine: 1) risk and protective factors of receiving cancer related follow-up care; 2) if the follow-up care received (based on medical records review) is consistent/adherent with published Long- Term Follow-up Guidelines (for patient specific cancer and clinical history); and, 3) the relationship between milestones of emerging adulthood (e.g., full-time employment, marriage, having children) and receipt of cancer related follow-up care. Adherence to guideline care will be assessed by a physician panel. Comparative analyses will be used to identify differences by ethnicity and treatment site (cancer survivorship clinics and at
primary care/community clinics). Results from this population-based study will provide guidance to identify and reduce health inequities observed between Hispanic and non-Hispanic CCS in health care utilization, late effects, and ultimately, long term survival. Results can guide education/policy efforts focused on clinicians who treat Hispanic CCS as well as support specialized transition clinics and health promotion efforts focused on CCS entering emerging adulthood.
描述(由申请人提供):尽管生存率有所提高,但儿童癌症幸存者(CCS)因其疾病和严格的治疗而处于晚期和长期影响的高风险中。西班牙裔CCS在生存研究中代表性不足,与非西班牙裔相比,在死亡率方面存在显着的健康不平等。虽然建议对CCS进行终身的、基于风险的随访治疗,但随着CCS进入初成年期,这种治疗的使用迅速下降。我们在两家医院接受CCS治疗的初步研究(调查年龄为14-26岁)表明,在成年早期(21-26岁),西班牙裔CCS患者的癌症相关随访护理明显低于非西班牙裔CCS患者。我们建议招募和调查一个以人群为基础的队列(n=1,232),包括18-39岁的新生成人西班牙裔(54%)和非西班牙裔CCS,以了解在接受推荐的随访护理方面的潜在不公平,以及可能不同地影响西班牙裔和非西班牙裔CCS健康结局的因素。我们的目的是确定:1)接受癌症相关随访治疗的风险和保护因素;2)如果接受的随访治疗(基于医疗记录审查)与已发表的长期随访指南(针对患者特定的癌症和临床病史)一致/符合;3)成年初期的里程碑(如全职工作、结婚、生孩子)与接受癌症相关的后续护理之间的关系。医师小组将评估对指南护理的依从性。比较分析将用于确定种族和治疗地点(癌症生存诊所和医院)的差异
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joel E Milam其他文献
Joel E Milam的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joel E Milam', 18)}}的其他基金
Indicators of Accelerated Aging in Asian American Childhood Survivors
亚裔美国童年幸存者加速衰老的指标
- 批准号:
10910604 - 财政年份:2023
- 资助金额:
$ 41.21万 - 项目类别:
Individual, cultural, and area-based factors associated with survivorship care among Asian/Asian American childhood cancer survivors
与亚裔/亚裔美国儿童癌症幸存者的生存护理相关的个人、文化和地区因素
- 批准号:
10693965 - 财政年份:2021
- 资助金额:
$ 41.21万 - 项目类别:
Individual, cultural, and area-based factors associated with survivorship care among Asian/Asian American childhood cancer survivors
与亚裔/亚裔美国儿童癌症幸存者的生存护理相关的个人、文化和地区因素
- 批准号:
10482384 - 财政年份:2021
- 资助金额:
$ 41.21万 - 项目类别:
Individual, cultural, and area-based factors associated with survivorship care among Asian/Asian American childhood cancer survivors
与亚裔/亚裔美国儿童癌症幸存者的生存护理相关的个人、文化和地区因素
- 批准号:
10275095 - 财政年份:2021
- 资助金额:
$ 41.21万 - 项目类别:
Reducing racial/ethnic inequities in childhood cancer survivorship
减少儿童癌症幸存者中的种族/民族不平等
- 批准号:
8885884 - 财政年份:2014
- 资助金额:
$ 41.21万 - 项目类别:
Reducing racial/ethnic inequities in childhood cancer survivorship
减少儿童癌症幸存者中的种族/民族不平等
- 批准号:
8773810 - 财政年份:2014
- 资助金额:
$ 41.21万 - 项目类别:
Risk compensation and pre-exposure prophylaxis use to prevent HIV infection
使用风险补偿和暴露前预防来预防 HIV 感染
- 批准号:
8603501 - 财政年份:2013
- 资助金额:
$ 41.21万 - 项目类别:
Risk compensation and pre-exposure prophylaxis use to prevent HIV infection
使用风险补偿和暴露前预防来预防 HIV 感染
- 批准号:
8730228 - 财政年份:2013
- 资助金额:
$ 41.21万 - 项目类别:
Substance use among adolescent and young adult Hispanic cancer survivors
青少年和年轻西班牙裔癌症幸存者的药物使用情况
- 批准号:
7811048 - 财政年份:2009
- 资助金额:
$ 41.21万 - 项目类别:
Substance use among adolescent and young adult Hispanic cancer survivors
青少年和年轻西班牙裔癌症幸存者的药物使用情况
- 批准号:
7942751 - 财政年份:2009
- 资助金额:
$ 41.21万 - 项目类别:
相似海外基金
Understanding of the onset and recurrence pattern of intractable acute lymphocytic leukemia based on clone analysis
基于克隆分析了解难治性急性淋巴细胞白血病的发病和复发模式
- 批准号:
20K08723 - 财政年份:2020
- 资助金额:
$ 41.21万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Novel Inhibitors of Multi-Drug-Resistant Mutants of BCR-ABL for the Treatment of Chronic Myelogenous Leukemia (CML) and Ph Positive Acute Lymphocytic Leukemia (ALL).
BCR-ABL 多重耐药突变体的新型抑制剂,用于治疗慢性粒细胞白血病 (CML) 和 Ph 阳性急性淋巴细胞白血病 (ALL)。
- 批准号:
9047400 - 财政年份:2015
- 资助金额:
$ 41.21万 - 项目类别:
The Role of Genetic Variants in Sensitivity to Methotrexate in Acute Lymphocytic Leukemia Survivors
遗传变异在急性淋巴细胞白血病幸存者对甲氨蝶呤敏感性中的作用
- 批准号:
319114 - 财政年份:2014
- 资助金额:
$ 41.21万 - 项目类别:
Fellowship Programs
Targeting the Bone Marrow Microenvironment In Acute Lymphocytic Leukemia
针对急性淋巴细胞白血病的骨髓微环境
- 批准号:
8595788 - 财政年份:2013
- 资助金额:
$ 41.21万 - 项目类别:
Targeting hypoxic microenvironment in Acute Lymphocytic Leukemia
针对急性淋巴细胞白血病的缺氧微环境
- 批准号:
8023518 - 财政年份:2011
- 资助金额:
$ 41.21万 - 项目类别:
Targeting hypoxic microenvironment in Acute Lymphocytic Leukemia
针对急性淋巴细胞白血病的缺氧微环境
- 批准号:
8404025 - 财政年份:2011
- 资助金额:
$ 41.21万 - 项目类别:
Targeting hypoxic microenvironment in Acute Lymphocytic Leukemia
针对急性淋巴细胞白血病的缺氧微环境
- 批准号:
8220724 - 财政年份:2011
- 资助金额:
$ 41.21万 - 项目类别:
Targeting hypoxic microenvironment in Acute Lymphocytic Leukemia
针对急性淋巴细胞白血病的缺氧微环境
- 批准号:
8599754 - 财政年份:2011
- 资助金额:
$ 41.21万 - 项目类别:
INSULIN RESISTANCE IN CHILDREN WITH ACUTE LYMPHOCYTIC LEUKEMIA UNDERGOING INDUCT
正在接受治疗的急性淋巴细胞白血病儿童的胰岛素抵抗
- 批准号:
8356701 - 财政年份:2010
- 资助金额:
$ 41.21万 - 项目类别:
INSULIN RESISTANCE IN CHILDREN WITH ACUTE LYMPHOCYTIC LEUKEMIA UNDERGOING INDUCT
正在接受治疗的急性淋巴细胞白血病儿童的胰岛素抵抗
- 批准号:
8166720 - 财政年份:2009
- 资助金额:
$ 41.21万 - 项目类别: